Insider Trading: Threshold Pharmaceuticals Inc (THLD.W)

THLD.W on CBOE When Trading NASDAQ Global Select Market

5.51USD
24 May 2013
Price Change (% chg)

$-0.11 (-1.96%)
Prev Close
$5.62
Open
$5.49
Day's High
$5.55
Day's Low
$5.48
Volume
800
Avg. Vol
2,998
52-wk High
$9.14
52-wk Low
$3.97

Search Stocks
GAITHER JAMES C
Trading Date Type Shares Traded Price Shares Held
8 Dec 2011 Buy 14,641 $0.00 55,613
Previous Page 1 of 1

Institutional Holders

% Shares Owned: 74.61%
# of Holders: 125
Total Shares Held: 42,192,626
3 Mo. Net Change: -3,521,323
# New Positions: 16
# Closed Positions: 16
# Increased Positions: 59
# Reduced Positions: 46
# Net Buyers: 13

Officers & Directors

Name Age Since Current Position

Harold Selick

 58 Chief Executive Officer, Director

Stewart Kroll

 54 2011 Senior Vice President - Biostatistics and Clinical Operations

Mark Matteucci

 59 2007 Senior Vice President - Discovery Research

Joel Fernandes

 43 2011 Vice President - Finance, Controller

Tillman Pearce

 56 2012 Chief Medical Officer

Jeffrey Bird

 52 2008 Independent Director

Bruce Cozadd

 49 2005 Independent Director

David Hoffmann

 68 2007 Independent Director

Wilfred Jaeger

 57 2001 Independent Director

George Parker

 74 2004 Independent Director

David Parkinson

 62 2010 Independent Director

Laura Hansen

 IR Contact
Search Stocks